BioSpectra Inc. (BSI), is a privately-owned manufacturer of premium pharmaceutical ingredients and bulk, cGMP fine chemicals, in service to many leading BioPharma companies around the world. We offer innovative purification and synthetic capabilities to produce finished cGMP products, that serve to enhance every stage of the drug manufacturing process – upstream, midstream and downstream. As a leader in cGMP manufacturing, our portfolio includes bulk GMP biological buffers, GMP Buffer Solutions, GMP process fine-chemicals, as well as new chemical entities (NCEs) produced at IPEC & ICH Q7 regulatory compliance levels. We specialize in small molecule synthesis and true, phase-change multi-step purification, providing solutions for various cGMP key ingredient issues at various stages of the drug manufacturing process.
Looking for a particular BioSpectra, Inc. employee's phone or email?
The BioSpectra, Inc. annual revenue was $8 million in 2026.
Richard Mutchler is the CEO of The BioSpectra Organization of BioSpectra, Inc..
109 people are employed at BioSpectra, Inc..
BioSpectra, Inc. is based in Bangor, Pennsylvania.